Weak shipments of food-related products in the Fine Chemicals Division
First written in FY2019-Q3. 1 of 3 entries say "Restated". Latest entry: FY2020.
No other company in this theme has enough history to compare yet.
- FY2020DroppedAnnual report
「The Fine Chemicals segment reported revenue of ¥1,850 million, up ¥90 million, or 5.6%, from the previous fiscal year, due to rush demand ahead of the consumption tax increase and higher product unit prices.」
This filing does not explicitly mention the weak shipments of food-related products described through the previous fiscal year, and instead reports revenue growth for the segment as a whole driven by rush demand and higher unit prices. - FY2019RestatedAnnual report
「The Fine Chemicals segment reported revenue of ¥1,750 million, up ¥10 million, or 0.6%, year on year. Shipments of pharmaceutical products remained firm, while shipments of food-related products remained weak, leaving revenue broadly in line with the previous year.」
The full-year results also describe the pattern of firm shipments for pharmaceutical applications alongside weak shipments of food-related products. - FY2019-Q3First statedAnnual report
「The Fine Chemicals segment reported revenue of ¥1,310 million, down ¥4 million, or 0.4%, year on year. Shipments of pharmaceutical products remained firm, but shipments of food-related products remained weak, leaving revenue broadly in line with the previous year.」
In the Fine Chemicals segment, shipments for pharmaceutical applications remained firm, while weak shipments of food-related products resulted in a 0.4% year-on-year decline in revenue.